B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

AVPR2

MOLECULAR TARGET

arginine vasopressin receptor 2

UniProt: P30518NCBI Gene: 5548 compounds

AVPR2 (arginine vasopressin receptor 2) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting AVPR2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Arginine Vasopressin3.2625
2Oxytocin2.7715
3Deamino Arginine Vasopressin2.087
4Quercetin1.614
5Clotrimazole1.614
6Lypressin1.102
7Ornipressin1.102
8Chlorhexidine0.691

About AVPR2 as a Drug Target

AVPR2 (arginine vasopressin receptor 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented AVPR2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

AVPR2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.